You are here

Article metrics

Article menu

Download PDFPDF

Therapeutics/Prevention
Randomised controlled trial
Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes
Free

 

Online download statistics by month:

Online download statistics by month: March 2017 to March 2024

AbstractFullPdf
Mar 201718217035
Apr 20173919642
May 20173015836
Jun 2017498316
Jul 2017694316
Aug 2017773818
Sep 201770428
Oct 2017724418
Nov 2017633017
Dec 2017422416
Jan 201862408
Feb 2018573212
Mar 2018875115
Apr 2018572910
May 201836185
Jun 201835245
Jul 201830214
Aug 201838133
Sep 2018362310
Oct 2018501810
Nov 2018242413
Dec 201816161
Jan 2019353317
Feb 2019323025
Mar 2019222123
Apr 2019252423
May 2019252517
Jun 201922227
Jul 2019212117
Aug 2019131310
Sep 2019313116
Oct 2019323214
Nov 201919189
Dec 201916106
Jan 202015157
Feb 202016167
Mar 202010106
Apr 202015156
May 2020992
Jun 202010103
Jul 202015156
Aug 202026266
Sep 2020292831
Oct 2020191912
Nov 2020141410
Dec 2020889
Jan 2021983
Feb 2021181713
Mar 202113107
Apr 2021181815
May 2021665
Jun 202114145
Jul 202118178
Aug 2021161621
Sep 2021111110
Oct 2021222124
Nov 2021191818
Dec 2021181811
Jan 202210105
Feb 202222228
Mar 202222216
Apr 2022636210
May 2022333318
Jun 2022413913
Jul 202216176
Aug 202228263
Sep 2022282815
Oct 202225238
Nov 2022252510
Dec 2022997
Jan 202315135
Feb 202327273
Mar 20236610
Apr 2023997
May 2023999
Jun 20237711
Jul 202310107
Aug 2023232123
Sep 202316154
Oct 2023202011
Nov 2023282421
Dec 202324185
Jan 202414149
Feb 202430177
Mar 2024251943
Total246723201031